Gossamer Bio, Inc. (GOSS)
After hours:
| Previous Close | 0.7713 |
| Open | 0.7880 |
| Bid | 0.7336 x 400 |
| Ask | 0.7714 x 200 |
| Day's Range | 0.6900 - 0.8045 |
| 52 Week Range | 0.4530 - 1.8800 |
| Volume | |
| Avg. Volume | 1,461,188 |
| Market Cap | 167.402M |
| Beta (5Y Monthly) | 1.74 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1800 |
| Earnings Date | May 07, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.72 |
Business WireGossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
SAN DIEGO, May 03, 2024--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced the publication of its TORREY Phase 2 study manuscript in the Lancet Respiratory Medicine journal. The paper, titled "Seralutinib in Adults with Pulmonary Arterial Hypertension (T
Simply Wall St.Gossamer Bio Decline Means Insider Profits Down To US$17k
Insiders who bought Gossamer Bio, Inc. ( NASDAQ:GOSS ) stock lover the last 12 months are probably not as affected by...
Insider Monkey13 Best Biotech Stocks To Buy Under $20
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
